GPX3 and neurocutaneous syndrome: Serum GPX3 activity was significantly lower in the group of children with phacomatosis in comparison with the other paediatric patients (Figure 5C); GPX3: 172.4 ± 36.5 vs. 192.6 ± 46.8 U/L, p = 0.012).